2015
DOI: 10.1369/0022155415595670
|View full text |Cite
|
Sign up to set email alerts
|

The Study of Glioma by Xenotransplantation in Zebrafish Early Life Stages

Abstract: SummaryZebrafish (Danio rerio) and their transparent embryos are becoming an increasingly popular tool for studying processes involved in tumor progression and in the search for novel tumor treatment approaches. The xenotransplantation of fluorescently labeled mammalian cancer cells into zebrafish embryos is an approach enabling relatively high-throughput in vivo analyses. The small size of the embryos as well as the relative simplicity of their manipulation and maintenance allow for large numbers of embryos t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
39
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 35 publications
(39 citation statements)
references
References 90 publications
0
39
0
Order By: Relevance
“…More recently, zebrafish have been exploited to analyze tumor development and for chemical screens ( Peal et al, 2010 ; Lally et al, 2007 ), leading to the identification of several candidate therapeutics for melanoma and leukemia that are currently being evaluated in patients (NCT02354417, NCT01611675 and NCT01512251; White et al, 2013 ; Konantz et al, 2012 ). Glioma cells have previously been transplanted into zebrafish ( Vittori et al, 2015 ). In several studies, serum-grown adherent glioma cell lines were transplanted into the yolk to analyze angiogenesis and tumor growth and showed that these cells formed tumors on the yolk, promoted angiogenesis and were responsive to therapeutics ( Geiger et al, 2008 ; Zhao et al, 2009 ; Lally et al, 2007 ; Yang et al, 2013 ).…”
Section: Introductionmentioning
confidence: 99%
“…More recently, zebrafish have been exploited to analyze tumor development and for chemical screens ( Peal et al, 2010 ; Lally et al, 2007 ), leading to the identification of several candidate therapeutics for melanoma and leukemia that are currently being evaluated in patients (NCT02354417, NCT01611675 and NCT01512251; White et al, 2013 ; Konantz et al, 2012 ). Glioma cells have previously been transplanted into zebrafish ( Vittori et al, 2015 ). In several studies, serum-grown adherent glioma cell lines were transplanted into the yolk to analyze angiogenesis and tumor growth and showed that these cells formed tumors on the yolk, promoted angiogenesis and were responsive to therapeutics ( Geiger et al, 2008 ; Zhao et al, 2009 ; Lally et al, 2007 ; Yang et al, 2013 ).…”
Section: Introductionmentioning
confidence: 99%
“…A potentially interesting example is the zebrafish ( Danio rerio ) model for the study of gliomas [154, 158]. Zebrafish embryos are increasingly used for cancer studies since the discovery that pathways of tumorigenesis are similar in humans and zebrafish [66].…”
Section: Preclinical Glioma Modelsmentioning
confidence: 99%
“…Zebrafish are an emerging model in glioma research [ 10 , 11 ], and xenotransplantation of human glioblastoma has proven to be a successful approach. In previous studies, fluorescently labelled or fluorescent protein-expressing glioblastoma cells were implanted in zebrafish, in order to observe tumour-associated angiogenesis, to determine the effects of drugs, and to study the involvement of signalling pathways, such as Wnt signalling, in tumour progression [ 12 , 13 , 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…One of the benefits of this model is that zebrafish embryos lack an adaptive immune system, obviating the need for immunosuppression [ 16 ]. Another advantage is the transparency of the embryos, which makes imaging of tumour progression at single cell resolution easier than in mammalian models [ 10 , 13 , 17 ]. Furthermore, the fecundity of zebrafish, and the low cost of maintenance and experimentation, are advantages of the zebrafish model, that holds great promise for its use in drug screening in vivo [ 18 , 19 , 20 ].…”
Section: Introductionmentioning
confidence: 99%